• Drug: Harvoni (ledipasvir/sofosbuvir)
  • Manufacturer: Gilead

  • Route of Administration: Oral

  • Site of Care: Outpatient

  • Approved Indication: treatment of chronic hepatitis C virus in adults and pediatric patients 3 years of age and older with either

    • genotype 1, 4, 5, or 6 without cirrhosis or with compensated cirrhosis
    • genotype 1 with decompensated cirrhosis in combination with ribavirin
    • genotype 1 or 4 infection who are liver transplant recipients without cirrhosis or with compensated cirrhosis in combination with ribavirin

  • Disease: chronic viral hepatitis C

  • Therapeutic Area: Infectious disease, Gastroenterology, Hepatology
  • Enrollment Form Link: mysupportpath.com/liver
  • Phone Number: 1-855-7-MYPATH (1-855-769-7284)

  • Fax Number: 1-855-298-8700

  • Product Website: harvoni.com